Start Date

5-27-2021 9:00 AM

End Date

5-27-2021 5:00 PM

Description

  • Our institution has developed a multidisciplinary pulmonary embolism response team (PERT) to help in the management of patients with intermediate high risk pulmonary embolism
  • While the PERT focus is on acute inpatient management, it is important that PERT patients have close follow-up to monitor for known future complications including thromboembolic pulmonary hypertension (CTEPH) and chronic pulmonary embolism syndrome
  • CTEPH, in particular, is a potentially treatable disease with significant morbidity if left untreated
  • Therefore, an underappreciated and important aspect of the PERT team should be the coordinated follow-up and long term care of these patients
  • We wanted to better understand how consistently our patients with intermediate high risk PE had pulmonary and/or vascular medicine (JATS) outpatient follow-up with repeat TTE performed at 3 months

Keywords

PERT, Pulmonary Embolism, Outpatient

Comments

Presented at the 2021 House Staff Quality Improvement and Patient Safety Conference

Included in

Pulmonology Commons

Share

COinS
 
May 27th, 9:00 AM May 27th, 5:00 PM

Quality of Post-Discharge Follow-Up in Patients Admitted to TJUH with Intermediate High Risk Pulmonary Embolism

  • Our institution has developed a multidisciplinary pulmonary embolism response team (PERT) to help in the management of patients with intermediate high risk pulmonary embolism
  • While the PERT focus is on acute inpatient management, it is important that PERT patients have close follow-up to monitor for known future complications including thromboembolic pulmonary hypertension (CTEPH) and chronic pulmonary embolism syndrome
  • CTEPH, in particular, is a potentially treatable disease with significant morbidity if left untreated
  • Therefore, an underappreciated and important aspect of the PERT team should be the coordinated follow-up and long term care of these patients
  • We wanted to better understand how consistently our patients with intermediate high risk PE had pulmonary and/or vascular medicine (JATS) outpatient follow-up with repeat TTE performed at 3 months